Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1999
11/11/1999CA2328483A1 Inhibitors of nf-kb activation
11/11/1999CA2328476A1 Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery
11/11/1999CA2328132A1 Growth-associated protease inhibitor heavy chain precursor
11/11/1999CA2328108A1 Use of neglected target tissue antigens in modulation of immune responses
11/11/1999CA2327550A1 Melanocortin 1 receptor selective compounds
11/11/1999CA2327539A1 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
11/11/1999CA2327530A1 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/11/1999CA2327526A1 Thrombolytic agents derived from streptokinase
11/11/1999CA2327509A1 Pth2 receptor selective compounds
11/11/1999CA2327507A1 Succinamide inhibitors of interleukin-1.beta. converting enzyme
11/11/1999CA2327355A1 Human receptor molecules
11/11/1999CA2327262A1 Methods of raising animals for meat production
11/11/1999CA2327259A1 Human transcriptional regulator molecules
11/11/1999CA2326671A1 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction)
11/11/1999CA2326402A1 Preparation of human papillomavirus e1 having helicase activity and method therefor
11/11/1999CA2326065A1 Method for treating cytokine mediated hepatic injury
11/11/1999CA2325387A1 Method for treating ischemia
11/11/1999CA2295510A1 Use of a nuclease inhibitor or interleukin-10 (il-10) for the preparation of a therapeutic composition for improving transfection of a polynucleotide into a cell and compositions useful in gene therapy
11/11/1999CA2271837A1 1,2,5,-trisubstituted 1,2,-dihydroindazol-3-ones having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicaments
11/10/1999EP0955309A1 Inhibitors and substrates of thrombin
11/10/1999EP0955299A1 Benzothiophene, benzofurane and indole derivatives, process for their preparation and pharmaceutical compositions containing them
11/10/1999EP0955295A1 Therapeutically active levorotatory and dextrorotatory 1-((4-chlorophenyl)phenylmethyl) piperazines
11/10/1999EP0955294A2 Imidazolyl-alkenoic acid
11/10/1999EP0955056A1 Recombinant colony stimulating factor-1 for treatment of fungal infection
11/10/1999EP0955055A2 FGF inhibitor, angiogenesis inhibitor and antitumor agent containing complestatin or its derivative as effective ingredient
11/10/1999EP0954983A2 Methods of using isomer enriched conjugated linoleic acid compositions
11/10/1999EP0954975A2 Isomer enriched conjugated linoleic acid compositions
11/10/1999EP0954588A1 Ob fusion protein compositions and methods
11/10/1999EP0954585A2 Human telomerase catalytic subunit
11/10/1999EP0954580A1 Human sdf-5 protein and compositions
11/10/1999EP0954578A1 Glycoprotein hormone superagonists
11/10/1999EP0954575A2 Cerebellum and embryo specific protein
11/10/1999EP0954565A1 Adipogenic differentiation of human mesenchymal stem cells
11/10/1999EP0954532A1 Novel human apoptosis regulator
11/10/1999EP0954526A2 Serine protease inhibitors
11/10/1999EP0954521A1 4- (thien-3-yl)methyl] imidazole derivatives having alpha2-adrenoceptor agonistic activity
11/10/1999EP0954334A1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
11/10/1999EP0954325A1 Method for the specific immunoadsorption of selected pathogenic factors
11/10/1999EP0954320A1 Inositol polyphosphate derivatives and methods of using same
11/10/1999EP0954313A1 Method for treating tumors having high ldl requirements employing mtp inhibitors
11/10/1999EP0954308A1 Therapeutic treatment for cardiovascular diseases
11/10/1999EP0954305A2 Use of carbonic anhydrase inhibitors for treating macular edema
11/10/1999EP0954297A1 Use of bisphenolic compounds to treat type ii diabetes
11/10/1999EP0954279A2 Pharmaceutical, cosmetic composition with base of microbial culture mixed with an essential oil and an acid
11/10/1999EP0863873B1 Indole carbamates as leukotriene antagonists
11/10/1999CN1234835A Gene therapy for congestive heart failure
11/10/1999CN1234803A N heterocyclic substituted adenosine derivatives
11/10/1999CN1234801A 3-methylamide derivatives of 5H-pyrrolo [2,1,-C] [1,4]-benzodiazepines
11/10/1999CN1234791A Inhibition of matrix metalloproteases by 2-('omega'-aroylalkyl)-4-biaryl-oxobutyric acids
11/10/1999CN1234740A Process to obtain oestrogens from mare's urine
11/10/1999CN1234735A Method for treating skin pigmentation
11/10/1999CN1234398A Process for preparing alpha-adrenergic aceptor antagonist
11/10/1999CN1234396A Process for alkylation of hindered sulfamide
11/10/1999CN1234271A Capsule for treatment of rheumatic angitis and its preparation method
11/10/1999CN1234253A Health-care drink of nourishing spleen and kidney
11/10/1999CN1234229A Apparatus for treatment of immunomediated inflammatory disorders
11/10/1999CN1046285C Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
11/10/1999CN1046283C Process for preparation of 9-amino camptothecin
11/10/1999CN1046274C Isoxazoline compounds as antinflammatory agents
11/10/1999CN1046269C HIV protease inhibitors
11/09/1999US5981821 Dressing product with a calcium alginate matrix and method of production of the same
11/09/1999US5981791 High purity N-(4-[N,N-bis(2-iodoethyl)amino]phenoscycarbonyl)-L-glutamic acid
11/09/1999US5981762 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors
11/09/1999US5981755 Tachykinin antagonists
11/09/1999US5981731 Anticarcinogenic/antitumor/antiproliferative agents and diagnostic agents targeted against gene which codes for a protein kinase involved in signal transduction
11/09/1999US5981717 Mammalian tolloid-like gene and protein
11/09/1999US5981712 Antibody which binds to carboxyamido-triazole resistance protein; for detecting resistance to drug which prevents calcium influx in biological samples/cells
11/09/1999US5981710 Therapeutic hemoglobin composition having isotropically increased size
11/09/1999US5981604 Materials and methods for inhibiting bacterial cell wall biosynthesis
11/09/1999US5981601 Method for enhancing cellular bioenergy
11/09/1999US5981589 Copolymer-1 improvements in compositions of copolymers
11/09/1999US5981583 For use in the treatment of pathological conditions such as toxic shock, acute inflammatory conditions, acute phase response, atherosclerosis and cancer
11/09/1999US5981579 Use of nitrovasodilators for treatment of disease or stress conditions in a non-human mammal
11/09/1999US5981574 Phenanthrofuran derivatives
11/09/1999US5981571 Benzodioxa alkylene ethers as melatonergic agents
11/09/1999US5981570 Benzothiophene compounds, compositions, and methods
11/09/1999US5981568 Therapeutic inhibitor of vascular smooth muscle cells
11/09/1999US5981556 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
11/09/1999US5981547 Homochroman derivatives and related compounds useful as anti-inflammatory agents
11/09/1999US5981540 Selective delta opioid agonists and antagonists; useful as analgesics and in treating general neurologic disorders
11/09/1999US5981533 Pyrazole derivatives and processes for the preparation thereof
11/09/1999US5981531 For inhibiting platelet aggregation
11/09/1999US5981529 Substituted indolylpropyl-piperazine derivatives as 5-HT1D α agonists
11/09/1999US5981525 Indole derivatives useful in the treatment of osteoporosis
11/09/1999US5981516 Treating cholesterol without estrogenic activity at the uterine level in women comprising administering to women an amount of a steroid
11/09/1999US5981512 Means for treating radiation injuries
11/09/1999US5981506 Method for treating sinusitis with uridine triphosphates and related compounds
11/09/1999US5981491 Peptides; metalloenzymes; tumor necrosis factor
11/09/1999US5981490 Peptidyl compounds
11/09/1999US5981483 Compositions comprising modulators of cytokines of the TGF-β superfamily
11/09/1999US5981277 Polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
11/09/1999US5981251 PTP 1D: a novel protein tyrosine phosphatase
11/09/1999US5981246 Nucleic acids encoding EPH-like receptor protein tyrosine kinases
11/09/1999US5981245 Polypeptide kinase coded by a nucleic acid sequence; antibody development; for modulating kinase receptor activation and detecting receptor ligands
11/09/1999US5981222 Mammalian polynucleotide encoding protein factor; for disease prevention and treatment
11/09/1999US5981220 Nucleotide sequences coding protein associated with skin differentiation; diagnostic assays for detecting bone and skin disorders; treatment of osteoporosis, bone fractures
11/09/1999US5981168 Method and composition for modulating amyloidosis
11/09/1999US5980915 Administering an antiprotozoa agent
11/09/1999US5980865 Administering to the patient of a pharmaceutical composition containing about 0.005 to about 1.0 mg of ultra-low molecular weight heparins
11/09/1999CA2177780C New arylalkyl(thio)carboxamide compounds, their preparation processes and the pharmaceutical compositions that contain them
1 ... 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 ... 1564